|
|
Article: Epstein-Barr virus latent membrane protein can be therapeutic target.
- Article from:
- Cancer Weekly
- Article date:
- December 24, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 DEC 24 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a novel method for treating latent Epstein-Barr virus infection.
"Epstein-Barr virus (EBV) is a human herpesvirus that establishes a lifelong latent infection in the majority of the human population," explained Lori Cooper and colleagues at Northwestern University Medical School in Chicago. "In normal individuals, latent infection with EBV typically poses no health risk, but upon immunosuppression, either following organ transplantation or HIV infection, malignancies and lymphoproliferative diseases can result."
EBV's ...